Theranostics 2014; 4(5):475-486. doi:10.7150/thno.7729

Research Paper

Myocardial Protective Effect of Extracellular Superoxide Dismutase Gene Modified Bone Marrow Mesenchymal Stromal Cells on Infarcted Mice Hearts

Qiao Pan1*, Xing Qin1*, Sai Ma1*, Haichang Wang1*, Kang Cheng1, Xinxing Song1, Haokao Gao1, Qiang Wang2, Rannie Tao3, Yabin Wang1, Xiujuan Li1, Lize Xiong2✉, Feng Cao1,4✉

1. Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China;
2. Department of Anesthesia, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China;
3. Department of Medicine & Dentistry, University of Alberta, Canada;
4. Department of Cardiology, China PLA General Hospital, Beijing 100853, China.
* Qiao Pan, Xing Qin, Sai Ma and Haichang Wang contributed equally to this work.

Abstract

Aim: Extracellular superoxide dismutase (ecSOD) is a unique scavenger of superoxide anions and a promising target of gene therapy for ischemia/reperfusion injury (I/R). However, conventional gene therapies have limitation in effectiveness and efficiency. This study aimed to investigate the protective effects of ecSOD gene modified bone marrow mesenchymal stromal cells (BMSCs) on cardiac function improvement in mice infarcted heart. METHODS & RESULTS: BMSCs were isolated from Fluc+ transgenic mice (Tg FVB[Fluc+]) and transfected by adenovirus combined with human ecSOD gene. ELISA was performed to determine ecSOD protein level. Female syngeneic FVB mice were randomized into 5 groups: (1) Sham group (sham); (2) MI group (MI); (3) MI+BMSCs group (BMSC); (4) MI+BMSCs-vector group (BMSC-vector); (5) MI+ BMSCs-ecSOD group (BMSC-ecSOD). MI was accomplished by ligation of the left anterior descending artery. BMSCs (2x106) were injected into the border zone of infarction. In vivo bioluminescence imaging (BLI) was performed to monitor transplanted BMSCs viability. Echocardiography and histological staining revealed that BMSCs-ecSOD significantly reduced myocardial infarction size and improved cardiac function. Lucigenin chemiluminescence, DHE and TUNEL staining demonstrated that BMSCs-ecSOD delivery reduced ROS level and cell apoptosis both in vivo and in vitro. Western blot assay revealed that ecSOD supplementation increased FoxO3a phosphorylation in cardiomyocytes. Moreover, quantitative real-time PCR showed that pro-apoptotic factors (bim and bax) were decreased while the anti-apoptotic factor mir-21 expression was increased after ecSOD intervention. CONCLUSION: Intra-myocardial transplantation of adenovirus-ecSOD transfected BMSCs could exert potential cardiac protection against MI, which may be partly through reduction of oxidative stress and improvement of BMSCs survival.

Keywords: human extracellular superoxide dismutase, mesenchymal stromal cells, myocardial infarction, cell-based gene therapy, reactive oxygen species.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Pan Q, Qin X, Ma S, Wang H, Cheng K, Song X, Gao H, Wang Q, Tao R, Wang Y, Li X, Xiong L, Cao F. Myocardial Protective Effect of Extracellular Superoxide Dismutase Gene Modified Bone Marrow Mesenchymal Stromal Cells on Infarcted Mice Hearts. Theranostics 2014; 4(5):475-486. doi:10.7150/thno.7729. Available from http://www.thno.org/v04p0475.htm